Document is current
Any future updates will be listed below
-
Authors
Liu, Su
Xu, Huihui
Liu, Lijin
Ma, Wenjing
Fan, Hao
Liu, Fei
Wei, Ze
Hao, Jing
Zheng, Zhifa
Zhao, Lina
Yang, Bo
Wu, Zhihong
-
Funding
Funding for this research was provided by:
Postdoctoral Fellowship Program of China Postdoctoral Science Foundation (GZC20240144)
National Natural Science Foundation of China (82402893)
CAMS Special Project of Clinical and Translational Medical Research (2024-I2M-C&T-B-026)
National Key Research and Development Program of China (2022YFC2703901)
National High Level Hospital Clinical Research Funding (2022-PUMCH-D-002)
CAMS Innovation Fund for Medical Sciences (2021-I2M-1-052 and 2022-I2M-2-001)
- License Information
-
More Information
Article History
Received: 17 February 2025
Accepted: 23 June 2025
First Online: 7 July 2025
Declarations
:
: All animal experimental protocol has been carried out in accordance with relevant guidelines and all methods are reported in accordance with ARRIVE guidelines (). Animal studies were also approved by the Animal Welfare and Ethics Committee of TopBiotech Co., adhering to the guidelines for the care and use of laboratory animals.
: Written informed consent for publication of this paper was obtained from all authors.
: The authors declare no competing interests.
